These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23500266)

  • 1. Reply: To PMID 23219296.
    Waters DD; Boekholdt SM; Pedersen TR
    J Am Coll Cardiol; 2013 May; 61(18):1934. PubMed ID: 23500266
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin treatment and diabetes.
    Kennedy RL; Vangaveti V; Malabu UH
    J Am Coll Cardiol; 2013 May; 61(18):1933-4. PubMed ID: 23500211
    [No Abstract]   [Full Text] [Related]  

  • 3. How to balance cardiometabolic benefits and risks of statins.
    Koh KK
    J Am Coll Cardiol; 2013 May; 61(18):1932-3. PubMed ID: 23500235
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease.
    Sethi SS; Farkouh ME
    Ann Intern Med; 2013 Jul; 159(2):JC3. PubMed ID: 23856701
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive lipid lowering with atorvastatin in coronary disease.
    Cannon CP; Murphy SA; Braunwald E
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003832
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.
    Waters DD; Ho JE; Boekholdt SM; DeMicco DA; Kastelein JJ; Messig M; Breazna A; Pedersen TR
    J Am Coll Cardiol; 2013 Jan; 61(2):148-52. PubMed ID: 23219296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive lipid lowering with atorvastatin in coronary disease.
    Auer J; Lamm G; Eber B
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16000362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin wars: efficacy vs. cost.
    Wierzbicki AS
    Int J Clin Pract; 2011 Feb; 65(2):108-11. PubMed ID: 21235691
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive lipid lowering with atorvastatin in coronary disease.
    Southern W
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003831
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?
    Pitt B
    N Engl J Med; 2005 Apr; 352(14):1483-4. PubMed ID: 15755764
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statins after drug discontinuation are usually well tolerated].
    Steurer J
    Praxis (Bern 1994); 2013 Jun; 102(13):813. PubMed ID: 23773943
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
    Langer A
    N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16251546
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose statins and the IDEAL study.
    Mann SJ
    JAMA; 2006 Jun; 295(21):2477-8; author reply 2478-9. PubMed ID: 16757715
    [No Abstract]   [Full Text] [Related]  

  • 16. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins and antioxidant vitamins: should co-administration be avoided?
    Tousoulis D; Antoniades C; Stefanadis C
    J Am Coll Cardiol; 2006 Mar; 47(6):1237; author reply 1237-8. PubMed ID: 16545666
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of high-dose atorvastatin compared with usual-dose simvastatin: less than IDEAL?
    Kaul P
    Eur Heart J; 2007 Jun; 28(12):1405-6. PubMed ID: 17553925
    [No Abstract]   [Full Text] [Related]  

  • 19. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
    Klose G
    MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.